Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Merck & Co.'s new HIV protease inhibitors

Jan. 22, 1998

HIV protease inhibitor research continues at DuPont Merck

Jan. 21, 1998

New HIV vaccine from VaxGen cleared for phase I/II studies

Jan. 20, 1998

Provir set to enter final stage of development for AIDS-related diarrhea

Jan. 19, 1998

Peptide HIV protease inhibitors claimed by Merck & Co.

Jan. 19, 1998

Anti-HIV therapy with adefovir may also prevent the development of Kaposi's sarcoma

Jan. 16, 1998

Further mechanism of action studies described for AMD-3100

Jan. 16, 1998

Unimed submits NDA for AIDS-related illness

Jan. 16, 1998

Novel AIDS Rx technology available for licensing from NIH

Jan. 16, 1998

Three new AIDS vaccine trials examine novel approaches

Jan. 15, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...